Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Schalken

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 1, 1992
[The molecular basis of tumor progression in prostatic cancer]J A Schalken
European Urology|January 1, 1997
New perspectives in the treatment of prostate cancerJ A Schalken
Cancer Surveys|January 1, 1991
Molecular methods for predicting the metastatic potential of prostate cancerJ A Schalken
European Urology|January 1, 1990
The Heinrich Warner Prize 1989: the use of differential hybridization analysis to identify markers for diagnosis of urogenital cancerJ A Schalken
European Urology|June 6, 1998
Molecular prognostic factors in bladder cancerJ A Schalken
BJU International|March 11, 2004
Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasiaJ A Schalken
Prostate Cancer and Prostatic Diseases|July 15, 2009
Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancerP F Mulders, J A Schalken
World Journal of Urology|January 1, 1996
The role of cell adhesion molecules and proteases in tumor invasion and metastasisM J Bussemakers, J A Schalken
European Urology|January 1, 1992
Identification of new prostate cancer progression markers by differential hybridization analysisJ A Schalken, F M Debruyne
Cancer Metastasis Reviews|March 1, 1993
Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implicationsL A Giroldi, J A Schalken
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 1, 1992
[The molecular basis of tumor progression in prostatic cancer]J A Schalken
European Urology|January 1, 1997
New perspectives in the treatment of prostate cancerJ A Schalken
Cancer Surveys|January 1, 1991
Molecular methods for predicting the metastatic potential of prostate cancerJ A Schalken
European Urology|January 1, 1990
The Heinrich Warner Prize 1989: the use of differential hybridization analysis to identify markers for diagnosis of urogenital cancerJ A Schalken
European Urology|June 6, 1998
Molecular prognostic factors in bladder cancerJ A Schalken
BJU International|March 11, 2004
Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasiaJ A Schalken
Prostate Cancer and Prostatic Diseases|July 15, 2009
Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancerP F Mulders, J A Schalken
World Journal of Urology|January 1, 1996
The role of cell adhesion molecules and proteases in tumor invasion and metastasisM J Bussemakers, J A Schalken
European Urology|January 1, 1992
Identification of new prostate cancer progression markers by differential hybridization analysisJ A Schalken, F M Debruyne
Cancer Metastasis Reviews|March 1, 1993
Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implicationsL A Giroldi, J A Schalken
Pageof 20